valsartan

U.S. Food & Drug Administration News: FDA provides update on its ongoing investigation into valsartan products

WASHINGTON – The U.S. Food and Drug Administration is updating the public on the agency’s ongoing investigation surrounding the recent voluntary recall of several drug products containing the active pharmaceutical ingredient (API) valsartan, used to treat high blood pressure and heart failure. The FDA’s latest testing of products shows an additional unexpected impurity in three … Continue reading U.S. Food & Drug Administration News: FDA provides update on its ongoing investigation into valsartan products

FDA News: FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity

SILVER SPRINGS, MD – The U.S. Food and Drug Administration (FDA) is alerting health care professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure.  This recall is due to an impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled … Continue reading FDA News: FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity